Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (64739)	7/16/1999 10:27:00 PM
From: Gary Mohilner	Read Replies (1) \| Respond to of 132070

Michael, Are you familiar with ImmunoGen (IMGN). It's about to start Phase 1 Trials with it's lead drug. If successful, I believe it's Tumor Activated Prodrug (TAP) technology will be acknowledged to be the answer to curing most cancers as new drugs using the technology are developed. In simple terms their technology creates drugs that home in on the cancerous cells, kill them without killing the healthy cells around them, and exit the body with the dead cancerous cell by way of the bodies cleansing systems. The first drug huC242-DM1 is targeted at Colon, Pancreatic, and non-small cell Lung Cancer, and it may be effective against others. They have another drug that should be in trials for Small Cell Lung Cancer next year, and they're working with drugs for Breast and Prostate Cancer. I'm interested in what you think, Gary